Jedrzejek David sold $74K of LEVI

Jedrzejek David (SVP and General Counsel) sold 3,091 shares of LEVI STRAUSS & CO (LEVI) at $24.00 on 2026-11-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jedrzejek David
Published Nov 10, 2026, 11:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 11:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Bearish
high confidence
Mentioned
$LEVI
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVIBearishLow
01

Why it matters

The disclosed sale is the first public report of this insider's transaction, providing new data for investors.

02

Market read

A modest insider sale adds a data point for analysts but is unlikely to move the stock significantly.

03

What to watch

Potential tax‑loss harvesting or pre‑planned 10b5‑1 execution may mask the true intent.

Relevance 2/10Novelty 2/10Timing: same‑day filing

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.

Company-level read

Ticker impact

$LEVIBearishHigh confidence
Context

SVP and General Counsel Jedrzejek David sold 3,091 shares for $74,184 via a Form 4 filing.

Expected impact

modest downward pressure as the market prices the insider sell

Evidence & confidence

A $74K sale by a senior officer is a primary disclosure but the amount is small relative to market cap, limiting impact.

Market effects

Minimal; apparel sector not materially affected by a single insider sale.

None; the transaction is company‑specific.

Low; no broader market impact.

Counterpoint

The sale could be interpreted as routine portfolio rebalancing, not a negative signal.

Key entities

  • Jedrzejek David

    SVP and General Counsel of Levi Strauss & Co.

  • Levi Strauss & Co.

    Apparel manufacturer listed on NYSE under ticker LEVI.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVILow

Levi Strauss to shut down factory and retrench over 400 workers

Levi Strauss plans to close its Western Cape factory, retrenching over 400 workers. The company is offering voluntary severance packages. Labor and business groups express concern about local industrial capacity and unemployment. Levi's denies the closure is linked to the US removing South Africa from the African Growth and Opportunity Act. The company is still in consultation with employees.

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.